Purpose
to develop a new oral cholera vaccine using a single cholera strain that expresses antigens for both the Inaba and Ogawa serotypes, as well as produces cholera toxin subunits that act as an adjuvant to stimulate mucosal immune activity.
Grantee
Division
Global Health
Date
OCTOBER 2009
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
12
Grantee location
Gothenburg, Sweden
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.